Delivery Order SPE2DB20D1051-SPE2DB23FD7SK
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,047.50, is a delivery order for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $17,294.89 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication, to support military healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,855.18 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4564815698 WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. This order falls under AmerisourceBergen's existing $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceuticals and medical supplies for military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,967.86, is a Delivery Order for the product "WEGOVY 2.4 MG/0.75 ML PEN 0.75ML". The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,983.55 firm-fixed-price delivery order is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,218.16, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of October 22, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,213.03, is a delivery order for the medical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award has an ultimate completion date of January 7, 2025 and is a firm fixed price contract. There was no set-aside used for this award. The contract is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.50, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. It is a firm fixed-price delivery order contract with a period of performance through February 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a for-profit...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,714.80 firm-fixed-price delivery order is for WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a medication used in healthcare. The contract has a period of performance through February 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a broad range of...
- This federal contract award, valued at $2,047.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of June 9, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB23FD7SKDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,003.94 firm fixed-price delivery order contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication, to support military healthcare programs. This award is associated with AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to the U.S. military globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience and capabilities in distributing critical medical commodities, including specialty drugs, vaccines, and medical devices, make it a key vendor for federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 4/28/23 |